Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets

JI Jun, LF Lau - Nature reviews Drug discovery, 2011 - nature.com
Members of the CCN family of matricellular proteins are crucial for embryonic development
and have important roles in inflammation, wound healing and injury repair in adulthood …

[HTML][HTML] Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases

M Fu, D Peng, T Lan, Y Wei, X Wei - Acta Pharmaceutica Sinica B, 2022 - Elsevier
Connective tissue growth factor (CTGF), a multifunctional protein of the CCN family,
regulates cell proliferation, differentiation, adhesion, and a variety of other biological …

Recent findings on genetics of systemic autoimmune diseases

A Delgado-Vega, E Sánchez, S Löfgren… - Current opinion in …, 2010 - Elsevier
Association studies of over 1 million SNPs capturing most of the human genome common
variation became possible thanks to the information provided by the HapMap International …

[PDF][PDF] The genetics of systemic sclerosis: an update

E Romano, M Manetti, S Guiducci… - Clinical and …, 2011 - researchgate.net
Systemic sclerosis (SSc) is a complex systemic disease characterised by fibrosis of the skin
and internal organs, vasculopathy, and activation of the immune system. The complex …

Connective tissue growth factor (CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis

A Dendooven, KG Gerritsen, TQ Nguyen, RJ Kok… - Biomarkers, 2011 - Taylor & Francis
Background: Connective tissue growth factor (CTGF) has been identified as a key factor in
the pathogenesis of diseases with significant fibrosis-related complications such as …

[HTML][HTML] Systemic sclerosis is a complex disease associated mainly with immune regulatory and inflammatory genes

J Jin, C Chou, M Lima, D Zhou… - The open rheumatology …, 2014 - ncbi.nlm.nih.gov
Systemic sclerosis (SSc) is a fibrotic and autoimmune disease characterized clinically by
skin and internal organ fibrosis and vascular damage, and serologically by the presence of …

Genomic and genetic studies of systemic sclerosis: A systematic review

P Chairta, P Nicolaou, K Christodoulou - Human Immunology, 2017 - Elsevier
Systemic sclerosis is an autoimmune rheumatic disease characterised by fibrosis,
vasculopathy and inflammation. The exact aetiology of SSc remains unknown but evidences …

CCN proteins as potential actionable targets in scleroderma

P Henrot, ME Truchetet, G Fisher… - Experimental …, 2019 - Wiley Online Library
Systemic sclerosis (SS c) is a complex autoimmune connective tissue disease combining
inflammatory, vasculopathic and fibrotic manifestations. Skin features, which give their name …

Targeted therapies for systemic sclerosis

CP Denton, VH Ong - Nature Reviews Rheumatology, 2013 - nature.com
Pathogenic processes that underlie the development and progression of systemic sclerosis
(SSc) are being defined in preclinical, clinical and genetic studies. Important evidence of …

Evaluation of tear and aqueous humor level, and genetic variants of connective tissue growth factor as biomarkers for early detection of pseudoexfoliation syndrome …

BC Demirdöğen, CK Akçin, G Özge… - Experimental Eye …, 2019 - Elsevier
Pseudoexfoliation syndrome (PEX) may lead to the development of pseudoexfoliative
glaucoma (PEG), a potential cause of irreversible blindness, if left untreated. This type of …